These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

798 related articles for article (PubMed ID: 28480903)

  • 21. Hepatitis A virus cellular receptor 1/kidney injury molecule-1 is a susceptibility gene for clear cell renal cell carcinoma and hepatitis A virus cellular receptor/kidney injury molecule-1 ectodomain shedding a predictive biomarker of tumour progression.
    Cuadros T; Trilla E; Vilà MR; de Torres I; Vilardell J; Messaoud NB; Salcedo M; Sarró E; López-Hellin J; Blanco A; Mir C; Ramón y Cajal S; Itarte E; Morote J; Meseguer A
    Eur J Cancer; 2013 May; 49(8):2034-47. PubMed ID: 23352434
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predictive biomarkers in renal cell cancer: insights in drug resistance mechanisms.
    van der Mijn JC; Mier JW; Broxterman HJ; Verheul HM
    Drug Resist Updat; 2014; 17(4-6):77-88. PubMed ID: 25457974
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reduced expression of growth and differentiation factor-9 (GDF9) is associated with aggressive behaviour of human clear-cell renal cell carcinoma and poor patient survival.
    Du P; Ye L; Yang Y; Jiang WG
    Anticancer Res; 2014 Nov; 34(11):6515-20. PubMed ID: 25368253
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnostic and prognostic tissuemarkers in clear cell and papillary renal cell carcinoma.
    Kroeze SG; Bijenhof AM; Bosch JL; Jans JJ
    Cancer Biomark; 2010; 7(6):261-8. PubMed ID: 21694464
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Network-based metabolic characterization of renal cell carcinoma.
    Pandey N; Lanke V; Vinod PK
    Sci Rep; 2020 Apr; 10(1):5955. PubMed ID: 32249812
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clear cell renal cell carcinoma induces fibroblast-mediated production of stromal periostin.
    Bakhtyar N; Wong N; Kapoor A; Cutz JC; Hill B; Ghert M; Tang D
    Eur J Cancer; 2013 Nov; 49(16):3537-46. PubMed ID: 23896380
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Down-regulation of CD74 inhibits growth and invasion in clear cell renal cell carcinoma through HIF-1α pathway.
    Ji SQ; Su XL; Cheng WL; Zhang HJ; Zhao YQ; Han ZX
    Urol Oncol; 2014 Feb; 32(2):153-61. PubMed ID: 23273913
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The differential expression of vascular endothelial growth inhibitor isoforms, VEGI251, VEGI174 and VEGI192 in human clear-cell renal cell carcinoma.
    Zhang N; Wu P; Wu L; Shayiremu D; Shan H; Ye L; Jiang WG; Gong K; Yang Y
    Cancer Genomics Proteomics; 2013; 10(1):47-53. PubMed ID: 23382586
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of Toll-like receptor 3 as a potential therapeutic target in clear cell renal cell carcinoma.
    Morikawa T; Sugiyama A; Kume H; Ota S; Kashima T; Tomita K; Kitamura T; Kodama T; Fukayama M; Aburatani H
    Clin Cancer Res; 2007 Oct; 13(19):5703-9. PubMed ID: 17908959
    [TBL] [Abstract][Full Text] [Related]  

  • 30. pVHL co-ordinately regulates CXCR4/CXCL12 and MMP2/MMP9 expression in human clear-cell renal cell carcinoma.
    Struckmann K; Mertz K; Steu S; Storz M; Staller P; Krek W; Schraml P; Moch H
    J Pathol; 2008 Mar; 214(4):464-71. PubMed ID: 18189328
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of PGAM1 in renal clear cell carcinoma and its clinical significance.
    Li C; Shu F; Lei B; Lv D; Zhang S; Mao X
    Int J Clin Exp Pathol; 2015; 8(8):9410-5. PubMed ID: 26464696
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Integrative analysis of protein-coding and non-coding RNAs identifies clinically relevant subtypes of clear cell renal cell carcinoma.
    Li Z; Chen Y; Hu S; Zhang J; Wu J; Ren W; Shao N; Ying X
    Oncotarget; 2016 Dec; 7(50):82671-82685. PubMed ID: 27705920
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dicer suppresses MMP-2-mediated invasion and VEGFA-induced angiogenesis and serves as a promising prognostic biomarker in human clear cell renal cell carcinoma.
    Chen YS; Meng F; Li HL; Liu QH; Hou PF; Bai J; Zheng JN
    Oncotarget; 2016 Dec; 7(51):84299-84313. PubMed ID: 27732931
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ccRCC is fundamentally a metabolic disorder.
    Zaravinos A; Deltas C
    Cell Cycle; 2014; 13(16):2481-2. PubMed ID: 25486184
    [No Abstract]   [Full Text] [Related]  

  • 35. Decreased expression of EphA5 is associated with Fuhrman nuclear grade and pathological tumour stage in ccRCC.
    Wang X; Xu H; Wu Z; Chen X; Wang J
    Int J Exp Pathol; 2017 Feb; 98(1):34-39. PubMed ID: 28421649
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Expression of carbonic anhydrase IX, PAX2 and PAX8 and their association with clinicopathologic characteristics in renal epithelial tumors].
    Zhang W; Yu WJ; Xia Y; Liu Y; Liu XL; Zhuang J; Li YJ
    Zhonghua Bing Li Xue Za Zhi; 2013 Jul; 42(7):442-5. PubMed ID: 24246861
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fatty acid metabolism reprogramming in ccRCC: mechanisms and potential targets.
    Tan SK; Hougen HY; Merchan JR; Gonzalgo ML; Welford SM
    Nat Rev Urol; 2023 Jan; 20(1):48-60. PubMed ID: 36192502
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Proteomic identification of angiomotin by ProteomeLab PF-2D and correlation with clinical outcome in human clear cell renal cell carcinoma.
    Yang J; Liu P; Tian M; Li Y; Chen W; Li X
    Int J Oncol; 2013 Jun; 42(6):2078-86. PubMed ID: 23588948
    [TBL] [Abstract][Full Text] [Related]  

  • 39. GFOD1 and peejar are promising markers for clear-cell renal cell carcinoma disease progression.
    Wu XR; Chen YH; Chen W; Kong W; Huang JW; Zhang J; Xue W; Liu DM; Huang YR
    Oncotarget; 2016 Jun; 7(25):38004-38009. PubMed ID: 27191742
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of erythropoietin and neuroendocrine markers in clear cell renal cell carcinoma.
    Mjønes PG; Nordrum IS; Qvigstad G; Sørdal Ø; Rian LL; Waldum HL
    APMIS; 2017 Mar; 125(3):213-222. PubMed ID: 28233444
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 40.